EUVIMED · CrossrefZeitschrift
mAbs
ISSN 1942-0862 · Informa UK Limited
Neueste Artikel
Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection
Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells
Structure-guided design of antibody CDRs to reduce their reactivity to treatment-emergent anti-drug antibodies
Multidimensional maturation of antibody variable domains with machine-learning assistance
The making of multispecific immunoglobulins – a clinical perspective
Antibodies to watch in 2026
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production
Rapid and selective characterization of antibody-drug conjugates in complex sample matrices by native affinity liquid chromatography-mass spectrometry
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety
Alpseq : an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseases
NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody–antigen interactions
Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy
Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis
Using mass spectrometry for robust identity release testing in a global quality control network
Impact of afucosylation strategy on antibody function: a comparative study of glycoengineered anti-CD20 antibodies Obinutuzumab and Obinutuzumab beta
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis
Engineering of acidic pH-responsive anti-CD3 binding antibodies
Impact of process impurities on developability assessments of complex antibody formats: the striking role of leachable copper
Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3
Combination therapy with a novel CD2-targeted costimulatory bispecific antibody overcomes limitations of CD3 T cell engager treatment for solid tumors
NMR detects clustering and ultra-weak excipient interactions governing monoclonal antibody viscosity in formulation-relevant conditions
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle TM variants
Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry
Local electrostatics governs tryptophan oxidation and enables rational stability engineering in antibodies
SprintX: mitigating data scarcity in antibody design via synthetic structural prior knowledge dataset
Clonal tree frequency analysis reveals affinity determinants and enables antibody lead optimization
Beyond AlphaFold 3: a standardised benchmark of open-source co-folding models for antibody–antigen complexes, from docking accuracy to interaction specificity
Direct infusion intact mass spectrometry for rapid and sensitive characterization of antibody therapeutics in complex matrices
EUVIMED